Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.

Anne PaakinahoMarjaana KoponenMiia TiihonenMarkku KauppiSirpa HartikainenAnna-Maija Tolppanen

Published in: Neurology (2022)

This study provides Class II evidence that in individuals with rheumatoid arthritis using DMARDs, only chloroquine/hydroxychloroquine was associated with a potentially decreased risk of developing PD (adjusted OR 0.74, 95% CI 0.56-0.97).

Keyphrases

rheumatoid arthritis
parkinson disease
disease activity
deep brain stimulation
rheumatoid arthritis patients
interstitial lung disease
ankylosing spondylitis
systemic lupus erythematosus
systemic sclerosis
drug induced
plasmodium falciparum